Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
GSK Receives US FDA File Acceptance for Jemperli (dostarlimab) plus Chemotherapy for the Treatment of dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer
GSK has announced the US Food and Drug Administration (FDA) accepted the supplemental Biologics License […]
PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial
PathAI, a leading provider of AI-powered pathology, today announced its partnership with GSK on HORIZON, […]
Phase III RUBY Clinical Trial Shows Jemperli Could Redefine Cancer Treatment
GSK today announced interim results from Part 1 of the RUBY/ENGOT-EN-6-NSGO/GOG3031 phase III trial investigating […]
China National Medical Products Administration Accepts Regulatory Submission for Nucala (mepolizumab) in Severe Eosinophilic Asthma
GSK today announced that the China National Medical Products Administration has accepted for review a […]
ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva is as effective as daily oral Biktarvy for the treatment of HIV-1
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi […]
U.S. FDA Grants Regular Approval for Jemperli for the Treatment of Patients with Recurrent or Advanced Mismatch Repair-deficient Endometrial Cancer
GSK reports that the US Food and Drug Administration (FDA) granted full approval for Jemperli (dostarlimab-gxly) […]
Jesduvroq Approved by US FDA for Anaemia of Chronic Kidney Disease in Adults on Dialysis
GSK today announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), […]
GSK Completes Acquisition of Sierra Oncology
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Sierra Oncology, Inc. […]
GSK Announces £1 Billion R&D Investment Over Ten Years to Get Ahead of Infectious Diseases in Lower-income Countries
GSK plc (LSE/NYSE: GSK) announced today an investment of £1bn over ten years to accelerate […]
GSK Presents Promising New Data for Bepirovirsen, an Investigational Treatment for Chronic Hepatitis B
GSK plc today announced promising interim results from the B-Clear phase IIb trial showing that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more